Background: Androgen ablation is often used in addition to low-dose-rate brachytherapy in the treatment of prostate cancer, particularly for disease with adverse features. We report a single ...

After obtaining formal institutional review board approval, the charts of 441 patients from 1996 to 2005 receiving low-dose-rate brachytherapy for prostate cancer at our institution were reviewed.

A report into recurrent prostate cancer by ... to androgen ablation from initial responsiveness. Thus, the broader application of early microenvironment-targeting therapy will rely on the ...

But in others, the cancer can be aggressive and deadly. Prostate cancer that's detected early has the best chance for successful treatment. One in eight men will get prostate cancer at some point ...

AngioDynamics has obtained an FDA green light for its NanoKnife prostate cancer ablation system ... function-preserving treatment for men with prostate tumors,” AngioDynamics’ president ...

Prostate cancer is the second leading cause of ... Ultrasound Fusion–Guided Nanoparticle-Directed Focal Therapy for Prostate Ablation, Journal of Urology (2024). DOI: 10.1097/JU.

The high-voltage pulses in IRE create permanent nanopores in membranes of cancer cells, inducing apoptotic-like cellular death in the target tissue. NanoKnife treatment involves no knives ...

The study found that Focal One's treatment methods match up with the gold star standard of surgery, and improve quality of life outcomes.

less onerous and less invasive than currently available treatment options. Prostate cancer that has spread beyond its ...

(NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving ...

European Union: The NanoKnife System is indicated for the ablation of prostate ... Focal minimally invasive treatment in localized prostate cancer: comprehensive review of different possible ...